Table 2. Univariate and multivariate Cox regression analysis on the contribution of various potential prognostic parameters to progression-free survival of patients with non-muscle-invasive BC.
Parameters | Categories | P-value | OR | 95% CI |
---|---|---|---|---|
Univariate Cox regression analysis | ||||
AIB1 expression | Normal vs over | 0.003 | 3.182 | 1.476–6.862 |
Gender | Male vs female | 0.145 | 0.407 | 0.122–1.361 |
Age (years) | ⩽60 vs >60 | 0.273 | 1.564 | 0.702–3.483 |
pT status | pTa vs pT1 | 0.002 | 3.252 | 1.522–6.946 |
WHO grade | Low vs high | 0.014 | 2.589 | 1.211–5.537 |
Multiplicity | Unifocal vs multifocal | 0.357 | 1.426 | 0.670–3.036 |
Tumour size (cm) | ⩽2.0 vs >2.0 | 0.021 | 2.603 | 1.158–5.847 |
Intravesical instillation |
MMC vs THP |
0.944 |
0.983 |
0.618–1.564 |
Multivariate Cox regression analysis | ||||
AIB1 expression | Normal vs over | 0.009 | 2.861 | 1.307–6.264 |
pT status | pTa vs pT1 | 0.003 | 3.296 | 1.520–7.148 |
WHO grade | Low vs high | 0.016 | 2.585 | 1.196–5.586 |
Tumour size (cm) | ⩽2.0 vs >2.0 | 0.068 | 2.144 | 0.945–4.866 |
Abbreviations: CI=confidence interval; MMC=mitomycin C; OR=odds ratio; pT=pathological T(TNM); THP=pirarubicin; WHO=World Health Organisation.